Effect of a Dairy Product for Pregnant and Lactating Women on the Composition of Human Milk

Effect of Consumption of a Dairy Product Designed for Pregnant and Lactating Women on the Composition of Human Milk. A Quasi-experimental Study in a Vulnerable Population

Vulnerable populations, who have deficient diets, may produce human milk (HML) that is not adequate in all nutrients, and this will have consequences on the growth and development of the child. In 2021, at IDIP, a specific milk product for pregnant and lactating women, Super Mil Mamá ( SMM, whole milk powder fortified with multiple vitamins, minerals, and DHA ) was designed and developed as part of a key strategy to incorporate into public policies for the first 1000 days of life. However, the potential benefits of this product have not yet been evaluated at the population level. The main objective is to evaluate the effect of the consumption of a milk product (SMM) designed for pregnant women on maternal nutritional status and the composition of human milk at one month postpartum.

Specific objectives include:

To compare the concentrations of DHA, Vitamins A, E, and D, Iron, Iodine, Zinc, and Calcium in human milk at one month postpartum of mothers who consumed SSM or not.

To compare the concentrations of DHA, Vitamins A, E, D and Zinc in blood and the nutritional status of maternal iron between mothers who consumed SSM and those who did not.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Buenos Aires
      • La Plata, Buenos Aires, Argentina, 1900
        • Recruiting
        • Instituto de Desarrollo e Investigaciones Pediátricas (IDIP) - HIAEP Sor María Ludovica
        • Contact:
      • La Plata, Buenos Aires, Argentina, 1900
        • Recruiting
        • Hospital Interzonal de Agudos General San Martín
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Intervention group: Pregnant women over 18 years of age who undergo prenatal care during gestational weeks (GW) 28 ± 1 at the Maternal Nutrition Clinic of the H.I.G.A. "San Martín" in La Plata, and who regularly consume milk, will be included.
  • Control group: Women over 18 years of age who attend their child's first checkup before the first month of life at the Maternal Clinic of the IDIP Health Observatory, and who exclusively breastfeed their children, will be included.

Exclusion Criteria:

  • Women who have had multiple pregnancies and/or women with malabsorption diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: Super 1.000 Mamá
Pregnant women who will consume a fortified powdered dairy product formulated and designed specifically for this population during pregnancy and the first month postpartum.
Super 1.000 Mamá It's made up of milk with added vegetable oils, fish oil, carbohydrates from corn, prebiotic fiber (inulin), vitamins, and minerals, with specifically defined proportions. It has medium energy content, is balanced in protein, fats, and carbohydrates, and provides a significant content of both polyunsaturated fatty acids, such as omega-6, and omega-3, and the added docosahexaenoic acid, as recommended by international organizations. The reconstituted 200 ml serving delivers between 20 and 40% of the Daily Reference Intake in critical nutrients for this particular group of people, which include minerals such as calcium, iron, zinc, iodine, and vitamins such as A, D, C, B12 and folic acid. The rest of the vitamins, and minerals are also at the same level, allowing those who consume it to incorporate a large amount of nutrients regularly. Addvance SA, an SME dairy company from the Province of Santa Fe, will carry out the production of this milk.
No Intervention: Sham Comparator: No milk consumption
Breastfeeding women who have not consumed SMM until the first month postpartum

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Breast milk DHA concentration
Time Frame: Time Frame: breast milk DHA concentration will be assessed at one month postpartum.
Description: concentration of DHA in breast milk expressed as a percentage of DHA with respect to the total fatty acids contained in the analyzed sample
Time Frame: breast milk DHA concentration will be assessed at one month postpartum.
Mother Zinc concentration
Time Frame: Mother Zinc concentration will be assessed at one month postpartum
Zinc concentration in mother serum expressed in mg/dl
Mother Zinc concentration will be assessed at one month postpartum
mother Vit E concentration
Time Frame: Mother's serum α-tocopherol concentration will be assessed at one month postpartum
α-tocopherol concentration in mother serum expressed in μmol/L
Mother's serum α-tocopherol concentration will be assessed at one month postpartum
Mother Vit A concentration
Time Frame: Mother's Vit A concentration will be assessed at one month postpartum
Retinol concentration in mother serum expressed in μmol/L
Mother's Vit A concentration will be assessed at one month postpartum
Mother red blood cell DHA concentration
Time Frame: Mother's serum DHA concentration will be assessed at one month postpartum
Concentration of DHA in mother's red blood cell expressed as a percentage of DHA with respect to the total fatty acids contained in the analyzed sample
Mother's serum DHA concentration will be assessed at one month postpartum
Mother hemoglobin concentration
Time Frame: Mother's hemoglobin concentration will be assessed one month postpartum
hemoglobin concentration in mother serum expressed in g/dL
Mother's hemoglobin concentration will be assessed one month postpartum
Breast milk Vitamin A concentration
Time Frame: Breast milk Vitamin A concentration will be assessed at one month postpartum
Retinol concentration in breast milk expressed in μmol/L and μg/g fat contained in the analyzed sample
Breast milk Vitamin A concentration will be assessed at one month postpartum
Breast milk Vitamin E concentration
Time Frame: Breast milk Vitamin E concentration will be assessed at one month postpartum
α-tocopherol concentration in breast milk expressed in μmol/L and μg/g fat contained in the analyzed sample
Breast milk Vitamin E concentration will be assessed at one month postpartum
Breast milk Vitamin D concentration
Time Frame: Breast milk Vitamin D concentration will be assessed at one month postpartum
25-hidroxi vitamin D concentration in breast milk expressed in ng/ml
Breast milk Vitamin D concentration will be assessed at one month postpartum
Breast milk Zinc concentration
Time Frame: Breast milk Zinc concentration will be assessed at one month postpartum
Zinc concentration in breast milk expressed in mg/dl
Breast milk Zinc concentration will be assessed at one month postpartum
Breast milk Calcium concentration
Time Frame: Breast milk Calcium concentration will be assessed at one month postpartum
Calcium concentration in breast milk expressed in mg/dl
Breast milk Calcium concentration will be assessed at one month postpartum
Breast milk Iron concentration
Time Frame: Breast milk Iron concentration will be assessed at one month postpartum
Iron concentration in breast milk expressed in mg/dl
Breast milk Iron concentration will be assessed at one month postpartum
Breast milk Iodine concentration
Time Frame: Breast milk Iodine concentration will be assessed at one month postpartum
Iodine concentration in breast milk expressed in mg/dl
Breast milk Iodine concentration will be assessed at one month postpartum
Mother serum ferritin concentration
Time Frame: Mother's serum ferritin concentration will be assessed at one month postpartum
ferritin concentration in mother serum expressed in ng/ml
Mother's serum ferritin concentration will be assessed at one month postpartum
mother Vit D concentration
Time Frame: mother Vit D concentration will be assessed at one month postpartum
25-hidroxi vitamin D concentration in mother serum expressed in ng/ml
mother Vit D concentration will be assessed at one month postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2025

Primary Completion (Estimated)

October 30, 2025

Study Completion (Estimated)

January 30, 2026

Study Registration Dates

First Submitted

September 8, 2025

First Submitted That Met QC Criteria

September 12, 2025

First Posted (Estimated)

September 15, 2025

Study Record Updates

Last Update Posted (Estimated)

September 15, 2025

Last Update Submitted That Met QC Criteria

September 12, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Clinical Trials on Fortified powder milk

Subscribe